Nystrom ML - Search Results

1

Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells.

Lewis MP, Lygoe KA, Nystrom ML, Anderson WP, Speight PM, Marshall JF, Thomas GJ. Lewis MP, et al. Among authors: nystrom ml. Br J Cancer. 2004 Feb 23;90(4):822-32. doi: 10.1038/sj.bjc.6601611. Br J Cancer. 2004. PMID: 14970860 Free PMC article.

2

Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.

Nystrom ML, McCulloch D, Weinreb PH, Violette SM, Speight PM, Marshall JF, Hart IR, Thomas GJ. Nystrom ML, et al. Cancer Res. 2006 Nov 15;66(22):10833-42. doi: 10.1158/0008-5472.CAN-06-1640. Cancer Res. 2006. PMID: 17108119

3

Development of a quantitative method to analyse tumour cell invasion in organotypic culture.

Nyström ML, Thomas GJ, Stone M, Mackenzie IC, Hart IR, Marshall JF. Nyström ML, et al. J Pathol. 2005 Mar;205(4):468-75. doi: 10.1002/path.1716. J Pathol. 2005. PMID: 15685705

4

Alphavbeta6 integrin in wound healing and cancer of the oral cavity.

Thomas GJ, Nyström ML, Marshall JF. Thomas GJ, et al. Among authors: nystrom ml. J Oral Pathol Med. 2006 Jan;35(1):1-10. doi: 10.1111/j.1600-0714.2005.00374.x. J Oral Pathol Med. 2006. PMID: 16393247 Review.

5

Measuring invasion in an organotypic model.

Jenei V, Nystrom ML, Thomas GJ. Jenei V, et al. Among authors: nystrom ml. Methods Mol Biol. 2011;769:223-32. doi: 10.1007/978-1-61779-207-6_15. Methods Mol Biol. 2011. PMID: 21748679

6

Cell migration and invasion assays.

Moutasim KA, Nystrom ML, Thomas GJ. Moutasim KA, et al. Among authors: nystrom ml. Methods Mol Biol. 2011;731:333-43. doi: 10.1007/978-1-61779-080-5_27. Methods Mol Biol. 2011. PMID: 21516419

7

Alpha v beta 6 integrin down-regulates the MMP-13 expression in oral squamous cell carcinoma cells.

Ylipalosaari M, Thomas GJ, Nystrom M, Salhimi S, Marshall JF, Huotari V, Tervahartiala T, Sorsa T, Salo T. Ylipalosaari M, et al. Exp Cell Res. 2005 Oct 1;309(2):273-83. doi: 10.1016/j.yexcr.2005.06.008. Exp Cell Res. 2005. PMID: 16024014

8

IPM chemotherapy in cytokine refractory renal cell cancer.

Shamash J, Steele JP, Wilson P, Nystrom M, Ansell W, Oliver RT. Shamash J, et al. Br J Cancer. 2003 May 19;88(10):1516-21. doi: 10.1038/sj.bjc.6600934. Br J Cancer. 2003. PMID: 12771915 Free PMC article. Clinical Trial.

9

Dose intense triplet chemotherapy with gemcitabine, carboplatin, paclitaxel with peripheral blood progenitor cell support for six cycles in advanced epithelial ovarian cancer.

Barlow C, Nystrom M, Oesterling C, Fennell D, Ismay J, Gallagher C. Barlow C, et al. Br J Cancer. 2004 Apr 5;90(7):1318-22. doi: 10.1038/sj.bjc.6601697. Br J Cancer. 2004. PMID: 15054448 Free PMC article. Clinical Trial.

10

Low-dose continuous chemotherapy for metastatic melanoma: a phase II trial.

Nystrom ML, Steele JP, Shamash J, Neville F, Oliver RT. Nystrom ML, et al. Melanoma Res. 2003 Apr;13(2):197-9. doi: 10.1097/00008390-200304000-00014. Melanoma Res. 2003. PMID: 12690305 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters